Internalized Stigma and its Correlates Among Opioid Agonist Treatment Service Users in Nepal DOI Creative Commons
Sagun Ballav Pant, Suraj Bahadur Thapa, John Howard

et al.

Journal of Psychosocial Rehabilitation and Mental Health, Journal Year: 2023, Volume and Issue: unknown

Published: Oct. 10, 2023

Abstract Opioid use disorder is associated with high levels of stigma and discrimination, which impact treatment seeking compliance. Despite extensive evidence as an optimal intervention for opioid disorder, enrollment in Agonist Treatment (OAT) settings like Nepal, accompanied by moral judgements a broad narrative it being merely replacement ‘one addiction another’. Stigma eventually internalized many service users impacting maintenance OAT, quality life. This study aimed to assess among OAT Nepal explore its association sociodemographic characteristics, lifetime mental disorders A cross-sectional was conducted 231 users, the survey instrument included Mini-International Neuropsychiatric Interview DSM-5, Internalized Mental Illness Inventory (ISMI) World Health Organization Quality Life –BREF. Factors life were investigated using bivariate multivariate analyses. More than half (56.28%) respondents reported having mean ISMI score 2.71 ± 0.64. All 29 items found have greater 2.5 indicating burden stigma. Service reporting higher had significantly lower across all domains, medical co-morbidity, anxiety depressive alcohol disorder. To lessen impacts, our findings recommend national initiative targeting reduction interventions existing services beneficiaries.

Language: Английский

Public Health Aspects and Interventions for Substance Use Disorders in South Asia DOI
Ravi Philip Rajkumar

Published: Jan. 1, 2024

Language: Английский

Citations

0
Internalized Stigma and its Correlates Among Opioid Agonist Treatment Service Users in Nepal DOI Creative Commons
Sagun Ballav Pant, Suraj Bahadur Thapa, John Howard

et al.

Journal of Psychosocial Rehabilitation and Mental Health, Journal Year: 2023, Volume and Issue: unknown

Published: Oct. 10, 2023

Abstract Opioid use disorder is associated with high levels of stigma and discrimination, which impact treatment seeking compliance. Despite extensive evidence as an optimal intervention for opioid disorder, enrollment in Agonist Treatment (OAT) settings like Nepal, accompanied by moral judgements a broad narrative it being merely replacement ‘one addiction another’. Stigma eventually internalized many service users impacting maintenance OAT, quality life. This study aimed to assess among OAT Nepal explore its association sociodemographic characteristics, lifetime mental disorders A cross-sectional was conducted 231 users, the survey instrument included Mini-International Neuropsychiatric Interview DSM-5, Internalized Mental Illness Inventory (ISMI) World Health Organization Quality Life –BREF. Factors life were investigated using bivariate multivariate analyses. More than half (56.28%) respondents reported having mean ISMI score 2.71 ± 0.64. All 29 items found have greater 2.5 indicating burden stigma. Service reporting higher had significantly lower across all domains, medical co-morbidity, anxiety depressive alcohol disorder. To lessen impacts, our findings recommend national initiative targeting reduction interventions existing services beneficiaries.

Language: Английский

Citations

0